Who is sponsoring NCT03198156?

NCT03198156 is sponsored by Ohio State University.

What drugs are being tested in NCT03198156?

Interventions in NCT03198156: Transcranial Direct Current Stimulation, Sham stimulation.

What condition does NCT03198156 study?

NCT03198156 studies Hypersomnia.

Is NCT03198156 still recruiting?

NCT03198156 is currently terminated. Last updated 25 October 2021.

Are results published for NCT03198156?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-10-25 · How we verify

NCT03198156: tDCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy

Terminated NA Results posted Last updated 25 October 2021

What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Hypersomnia in 39 participants. Terminated before completion.

Timeline

1 September 2017

Primary endpoint
20 June 2020

20 June 2020

Quick facts

Lead sponsor	Ohio State University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	39
Start date	1 September 2017
Primary completion	20 June 2020
Estimated completion	20 June 2020
Sites	1 location across United States

Drugs / interventions tested

Transcranial Direct Current Stimulation
Sham stimulation

Conditions studied

Hypersomnia — all drugs for Hypersomnia →

Sponsor

Ohio State University

Who can join

Adults 18 to 70, any sex, with Hypersomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance in subjects with central hypersomnia without cataplexy. 2. To determine the effects of tDCS on subjective measures of sleepiness and alertness in subjects with central hypersomnia without cataplexy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

NCT07496645 — EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE · Phase 3 · not yet recruiting
NCT07395531 — Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Par · Phase 3 · not yet recruiting
NCT07212634 — Cerebellar Transcranial Direct Current Stimulation for Dysphagia After Supratentorial Stroke · NA · not yet recruiting
NCT07319143 — The Effect of Transcranial Direct Current Stimulation (tDCS) in Improving Emotion Health · NA · recruiting
NCT06039605 — Priming Expectations and Motor Learning With tDCS · NA · completed

Other recruiting trials for Hypersomnia

Currently open trials in the same condition.

NCT06404099 — RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) · Phase 2 · active not recruiting
NCT05850676 — Disentangling the Role of Depression in Hypersomnia · recruiting

Other Ohio State University trials

Trials by the same sponsor.

NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03198156 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University
Last refreshed: 25 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03198156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing